Inhaled interferon- B/SNG001 to stimulate immune response in the virologic stage of the disease seems like a great therapy.

That does not take anything away from Leronlimab, as many will continued to have the immune dysregulation, with which we are all now familiar.

I don't believe that this is a zero sum game amongst vaccines, virologic treatments and immune modulators.

The big loser with Leronlimab and SNG001 would, IMO, be Remdesivir and Gilead. I doubt anyone here would be upset by that.